Malek Zihlif

986 total citations
78 papers, 742 citations indexed

About

Malek Zihlif is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Malek Zihlif has authored 78 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 18 papers in Cancer Research and 14 papers in Pharmacology. Recurrent topics in Malek Zihlif's work include Cancer, Hypoxia, and Metabolism (10 papers), Synthesis and biological activity (8 papers) and Asthma and respiratory diseases (6 papers). Malek Zihlif is often cited by papers focused on Cancer, Hypoxia, and Metabolism (10 papers), Synthesis and biological activity (8 papers) and Asthma and respiratory diseases (6 papers). Malek Zihlif collaborates with scholars based in Jordan, Australia and United States. Malek Zihlif's co-authors include Shatha AbuHammad, Mutasem O. Taha, Randa Naffa, Mustafa M. El‐Abadelah, Hamzeh J. Al‐Ameer, Mohammad S. Mubarak, Yazun Jarrar, Feda H. Hamdan, Manal A. Abbas and Fatma U. Afifi and has published in prestigious journals such as PLoS ONE, Scientific Reports and Molecules.

In The Last Decade

Malek Zihlif

73 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malek Zihlif Jordan 15 297 125 120 101 67 78 742
Thikryat Neamatallah Saudi Arabia 18 301 1.0× 86 0.7× 200 1.7× 65 0.6× 36 0.5× 41 865
Linda Bertoncelli Italy 12 506 1.7× 108 0.9× 110 0.9× 133 1.3× 55 0.8× 16 1.2k
Wenyu Wu China 20 470 1.6× 107 0.9× 168 1.4× 115 1.1× 55 0.8× 62 1.1k
Atif Zafar India 16 418 1.4× 166 1.3× 119 1.0× 69 0.7× 40 0.6× 28 1.2k
Lijuan Chen China 16 474 1.6× 79 0.6× 143 1.2× 92 0.9× 41 0.6× 28 995
Veronika Hanušová Czechia 16 406 1.4× 120 1.0× 79 0.7× 98 1.0× 32 0.5× 28 769
Luigi Quintieri Italy 20 461 1.6× 262 2.1× 118 1.0× 73 0.7× 36 0.5× 53 1.0k
Susana D. Lucas Portugal 18 345 1.2× 107 0.9× 273 2.3× 77 0.8× 37 0.6× 40 763
Alexandre F. Aissa Brazil 19 438 1.5× 122 1.0× 77 0.6× 143 1.4× 46 0.7× 48 967
Cong Huai China 14 493 1.7× 143 1.1× 44 0.4× 81 0.8× 45 0.7× 30 1.0k

Countries citing papers authored by Malek Zihlif

Since Specialization
Citations

This map shows the geographic impact of Malek Zihlif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malek Zihlif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malek Zihlif more than expected).

Fields of papers citing papers by Malek Zihlif

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malek Zihlif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malek Zihlif. The network helps show where Malek Zihlif may publish in the future.

Co-authorship network of co-authors of Malek Zihlif

This figure shows the co-authorship network connecting the top 25 collaborators of Malek Zihlif. A scholar is included among the top collaborators of Malek Zihlif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malek Zihlif. Malek Zihlif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al‐Ameer, Hamzeh J., Malek Zihlif, Wajdy Al‐Awaida, et al.. (2025). Targeting the proliferation of glioblastoma cells and enhancement of doxorubicin and temozolomide cytotoxicity through inhibition of PFKFB4 and HMOX1 genes with siRNAs. Scientific Reports. 15(1). 27861–27861. 3 indexed citations
2.
4.
Zihlif, Malek, et al.. (2024). Anti‐Inflammatory and Antioxidant Potential of Green Synthesized Iron Zinc Oxide (Fe0.25‐ZnO) Nanoparticles of the Elaeagnus angustifolia. Chemistry & Biodiversity. 21(9). e202401060–e202401060. 3 indexed citations
5.
Zihlif, Malek, et al.. (2024). Anti‑angiogenic and cytotoxic evaluation of green‑synthesized Fe2ZnO4 nanoparticles against MCF‑7 cell line. Biomedical Reports. 20(3). 36–36. 6 indexed citations
6.
Zihlif, Malek, et al.. (2024). Association between Toll-Like Receptor 4 Gene and inflammatory bowel disease among Jordanian patients. Pharmacy Practice. 22(4). 1–7. 1 indexed citations
7.
Al‐Hunaiti, Afnan, et al.. (2024). New Chitosan-Based Trimetallic Cu0.5Zn0.5Fe2O4 Nanoparticles:Preparation, Characterization, and Anti-cancer Activity. Pharmacy Practice. 22(4). 2 indexed citations
8.
Zihlif, Malek, et al.. (2024). Anti‐Inflammatory and Antioxidant Effects of Rosmarinic Acid Trimetallic (Cu0.5Zn0.5Fe2O4) Nanoparticles. Chemistry & Biodiversity. 21(5). e202301739–e202301739. 3 indexed citations
9.
Al-Kadash, Abdulfattah, et al.. (2024). Enhancing chemosensitivity of PANC1 pancreatic cancer cells to gemcitabine using ANGTPL4, Notch1 and NF-κβ1 siRNAs. Future Science OA. 10(1). FSO918–FSO918. 2 indexed citations
10.
11.
Lafi, Zainab, et al.. (2023). Echinomycin: A Journey of Challenges. Jordan Journal of Pharmaceutical Sciences. 16(3). 640–654. 8 indexed citations
13.
Amarin, Justin Z., et al.. (2020). Ononis natrix L. Lowers the Blood Glucose Concentration in Wistar Rats with Streptozotocin-induced Diabetes Mellitus. Endocrine Metabolic & Immune Disorders - Drug Targets. 21(5). 854–858. 1 indexed citations
14.
Hammad, Hana, et al.. (2019). Hypoxia-induced gene expression pattern in doxorubicin resistant MCF7 cells. Tropical Journal of Pharmaceutical Research. 18(8). 1589–1595. 2 indexed citations
15.
Hammad, Hana, et al.. (2017). In vitro and in vivo evaluation of the antiangiogenic activities of Trigonella foenum-graecum extracts. Asian Pacific Journal of Tropical Biomedicine. 7(8). 732–738. 7 indexed citations
16.
Zihlif, Malek, et al.. (2016). Association Between Gasdermin A and Gasdermin B Polymorphisms and Susceptibility to Adult and Childhood Asthma Among Jordanians. Genetic Testing and Molecular Biomarkers. 20(3). 143–148. 14 indexed citations
17.
Zalloum, Hiba, Rabab Tayyem, Yasser Bustanji, et al.. (2015). Discovery of new human epidermal growth factor receptor-2 (HER2) inhibitors for potential use as anticancer agents via ligand-based pharmacophore modeling. Journal of Molecular Graphics and Modelling. 61. 61–84. 5 indexed citations
18.
Zihlif, Malek, et al.. (2014). Association Between ADAM33 Polymorphisms and Susceptibility with Adult and Childhood Asthma Among Jordanians. Genetic Testing and Molecular Biomarkers. 18(11). 767–774. 9 indexed citations
19.
Zihlif, Malek, et al.. (2012). Frequency of Certain Single-Nucleotide Polymorphisms and Duplication of CYP2D6 in the Jordanian Population. Genetic Testing and Molecular Biomarkers. 16(10). 1201–1205. 8 indexed citations
20.
AbuHammad, Shatha & Malek Zihlif. (2012). Gene expression alterations in doxorubicin resistant MCF7 breast cancer cell line. Genomics. 101(4). 213–220. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026